From Lab to Life Bellberry Ltd

In The Quiet Achiever we met someone who has made an extraordinary contribution to Australian health in a career spanning over six decades. 
Professor Emeritus Lloyd Sansom AO started his career as a pharmacist, going on to become Professor of Pharmacy as well as Head of the School of Pharmacy and Medical Sciences at the University of South Australia.   
In 2002 he was awarded an AO and in 2004 his contribution to the University was recognised with the naming of the Sansom Institute for Health Research.  
He was also Chair of the Australian Pharmaceutical Advisory Council from 1991-2000 and Chair for the Pharmaceutical Benefits Advisory Committee from 2001-2012. 
Recently Lloyd retired as a member of Bellberry’s Board and in this episode he gives us insight into his life, work and lessons learnt.  

What are the changes in medical treatment that are going to affect us in the coming years? 
In our latest episode of From Lab to Life we hear from three researchers and Bellberry HREC members who have a front row seat to the latest developments.
On the Horizon reveals that one of the biggest influences on medical innovation is the pandemic. Despite having a devastating effect across the globe it has forced immense change in medical research.

In this episode of From Lab to Life, we hear the insights from some of the smartest researchers in the country about how they have succeeded in their careers.
In Speaking From Experience we hear from Laureate Professor Ingrid Scheffer, Professor Doug Hilton, Emeritus Professor Ian Frazer, Professors Marnie Blewitt, Kim Jacobson and Di Yu about how they have navigated a successful path in the complex and demanding field of medical research.

The competition for good workers is high. What keeps a staff member engaged and energised? At Bellberry, some staff intended to stay months, but have ended up staying for years.
What motivates an employee? And what’s the secret to having an engaged workforce?
In this episode of From Lab To Life, ‘All In A Day’s Work’, we meet the people that work every day for Bellberry.
 

Barely a month goes by without a media report of the next breakthrough in cancer or other rare and life-threatening diseases.  Unfortunately, it can take precious time for patients to receive the benefit of the latest medical innovation. 
In June 2023, Bellberry gathered representatives of regulators, reimbursement agencies, pharmaceutical companies and, most importantly, patient groups from around the globe to Adelaide, Australia, to examine the issue of accelerated access to potentially beneficial medicines. 
The challenge for the group was to agree on the principles to be considered when establishing processes to provide faster access to life-saving treatments. 
Gathering these experts in one place to focus on this difficult issue for three-and-a-half days was an achievement in itself. 
In this episode of From Lab To Life we meet some of the experts who attended this International Scientific Congress and hear their thoughts on this complex issue.

As a Not-For-Profit organisation, Bellberry allocates surplus funds raised from HREC review back into the health and medical research sector.  In this episode, ‘Chasing The Money’, we hear about Bellberry’s flagship philanthropic program, the Bellberry-Viertel Fellowship, and the impact this funding can have on research careers.